Cargando…
Design of an Anti-HMGB1 Synthetic Antibody for In Vivo Ischemic/Reperfusion Injury Therapy
[Image: see text] High-mobility group box 1 (HMGB1) is a multifunctional protein. Upon injury or infection, HMGB1 is passively released from necrotic and activated dendritic cells and macrophages, where it functions as a cytokine, acting as a ligand for RAGE, a major receptor of innate immunity stim...
Autores principales: | Koide, Hiroyuki, Kiyokawa, Chiaki, Okishima, Anna, Saito, Kaito, Yoshimatsu, Keiichi, Fukuta, Tatsuya, Hoshino, Yu, Asai, Tomohiro, Nishimura, Yuri, Miura, Yoshiko, Oku, Naoto, Shea, Kenneth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603801/ https://www.ncbi.nlm.nih.gov/pubmed/37844138 http://dx.doi.org/10.1021/jacs.3c06799 |
Ejemplares similares
-
Synthetic hydrogel nanoparticles for sepsis therapy
por: Koide, Hiroyuki, et al.
Publicado: (2021) -
Non-invasive evaluation of neuroprotective drug candidates for cerebral infarction by PET imaging of mitochondrial complex-I activity
por: Fukuta, Tatsuya, et al.
Publicado: (2016) -
Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke
por: Fukuta, Tatsuya, et al.
Publicado: (2022) -
Saturated fatty acid– and/or monounsaturated fatty acid–containing phosphatidic acids selectively interact with heat shock protein 27
por: Yachida, Naoto, et al.
Publicado: (2023) -
Epitope
Discovery for a Synthetic Polymer Nanoparticle:
A New Strategy for Developing a Peptide Tag
por: Yoshimatsu, Keiichi, et al.
Publicado: (2014)